PISCIOTTA, LIVIA
 Distribuzione geografica
Continente #
EU - Europa 14.206
AS - Asia 2.150
NA - Nord America 2.037
Continente sconosciuto - Info sul continente non disponibili 409
SA - Sud America 188
AF - Africa 34
OC - Oceania 5
Totale 19.029
Nazione #
IT - Italia 13.845
US - Stati Uniti d'America 1.890
SG - Singapore 759
CN - Cina 548
VN - Vietnam 365
BD - Bangladesh 231
FR - Francia 137
BR - Brasile 114
HK - Hong Kong 83
CA - Canada 62
DE - Germania 46
FI - Finlandia 39
MX - Messico 39
AR - Argentina 36
GB - Regno Unito 24
NL - Olanda 23
JP - Giappone 22
IN - India 20
IQ - Iraq 18
ID - Indonesia 16
RU - Federazione Russa 15
ES - Italia 13
PH - Filippine 11
UA - Ucraina 11
TH - Thailandia 10
TR - Turchia 9
CL - Cile 8
GT - Guatemala 8
PK - Pakistan 8
CH - Svizzera 7
CR - Costa Rica 7
EC - Ecuador 7
VE - Venezuela 7
ZA - Sudafrica 7
EG - Egitto 6
JM - Giamaica 6
SA - Arabia Saudita 6
AT - Austria 5
AU - Australia 5
CO - Colombia 5
HN - Honduras 5
IE - Irlanda 5
NI - Nicaragua 5
PL - Polonia 5
TW - Taiwan 5
DZ - Algeria 4
ET - Etiopia 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
PS - Palestinian Territory 4
PT - Portogallo 4
PY - Paraguay 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
GP - Guadalupe 3
PR - Porto Rico 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
UY - Uruguay 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BE - Belgio 2
BH - Bahrain 2
BJ - Benin 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
LB - Libano 2
LV - Lettonia 2
MA - Marocco 2
MD - Moldavia 2
PA - Panama 2
QA - Qatar 2
SE - Svezia 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BY - Bielorussia 1
CM - Camerun 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GR - Grecia 1
HT - Haiti 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LU - Lussemburgo 1
MG - Madagascar 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
NA - Namibia 1
OM - Oman 1
Totale 18.618
Città #
Genova 6.663
Genoa 4.676
Vado Ligure 1.098
Rapallo 1.014
San Jose 367
Singapore 352
Ashburn 303
Lauterbourg 124
Ho Chi Minh City 111
Beijing 102
Hanoi 93
New York 90
Council Bluffs 78
Hong Kong 77
St Louis 60
Santa Clara 56
Bordighera 41
Milan 38
Boardman 35
Los Angeles 33
Rome 33
Frankfurt am Main 31
Helsinki 31
Chicago 29
Buffalo 26
Dallas 25
Mexico City 24
Tokyo 21
Haiphong 17
Phoenix 17
Orem 16
Toronto 15
Atlanta 14
São Paulo 14
Da Nang 12
Florence 11
Tianjin 11
Miami 10
Naples 10
Turin 10
Verona 10
Amsterdam 9
Bologna 9
Camaiore 8
Washington 8
Biên Hòa 7
Brooklyn 7
Cleveland 7
Jacksonville 7
Lappeenranta 7
Montreal 7
San Francisco 7
Baghdad 6
Bari 6
Charlotte 6
Guatemala City 6
Houston 6
Las Vegas 6
London 6
Nuremberg 6
Palermo 6
Pescara 6
Philadelphia 6
Raleigh 6
San Diego 6
Seattle 6
Zurich 6
Alexandria 5
City of London 5
Denver 5
Des Moines 5
Detroit 5
Hải Dương 5
Kingston 5
Madrid 5
Milwaukee 5
Newark 5
Nha Trang 5
Riyadh 5
Salt Lake City 5
Addis Ababa 4
Alpharetta 4
Cagliari 4
Can Tho 4
Chennai 4
Columbus 4
Dublin 4
Duque de Caxias 4
Edmonton 4
Leiden 4
Managua 4
Monroe 4
Padua 4
Parma 4
Quảng Ngãi 4
Rio de Janeiro 4
Salvador 4
San Antonio 4
San José 4
Shenzhen 4
Totale 16.116
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 344
Manuale di dietistica e dietetica applicata. Vol. 2 279
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 228
Lipoproteins, stroke and statins. 219
A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla) 215
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 214
Short-term effect of rosuvastatin treatment on arterial stiffness in individuals with newly-diagnosed heterozygous familial hypercholesterolemia 196
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 193
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 192
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients. 191
Toward an international consensus-Integrating lipoprotein apheresis and new lipid-lowering drugs 190
A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment. 187
A “de novo” mutation of the LDL-receptor gene as the cause of familial hypercholesterolemia. 186
A silent mutation of Niemann-Pick C1-like 1 and apolipoprotein E4 modulate cholesterol absorption in primary hyperlipidemias. 183
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 179
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene. 177
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 175
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 172
Genetic polymorphisms affecting the phenotypic expression in familial hypercholesterolemia 171
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison. 170
An apparent inconsistency in parent to offspring transmission of point mutations of LDLR gene in familial hypercholesterolemia. 169
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 169
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 169
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). 168
Carotid ultrasonography in the assessment of cardiovascular risk 167
Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer 166
Timely diagnosis of sitosterolemia by next generation sequencing in two children with severe hypercholesterolemia 165
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. 164
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2 +5G>C mutation in ABCA1 gene 163
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study 162
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia. 162
A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene 161
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. 161
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 159
Adiponectin/leptin ratio predicts the remission of metabolic syndrome: A pilot study 158
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. 158
Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin. 156
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. 155
Efficacy of Nutraceutical Combination of Monacolin K, Berberine, and Silymarin on Lipid Profile and PCSK9 Plasma Level in a Cohort of Hypercholesterolemic Patients 155
Long term substrate reduction therapy with ezetimibe alone or associated with statins in three adult patients with lysosomal acid lipase deficiency 154
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 153
Severe HDL deficiency due to novel defects in the ABCA1 transporter. 152
Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations. 152
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 149
The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia 148
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 148
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia. 146
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e. 145
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 145
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency. 144
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs) 144
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 144
Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia. 142
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 140
PCSK9 inhibitors for treating hypercholesterolemia 139
Physical activity modulates effects of some genetic polymorphisms affecting cardiovascular risk in men aged over 40 years. 138
Two Italian Kindreds Carrying the Arg136>Ser Mutation of Apo E Gene: Development of Premature and Severe Atherosclerosis in the presence of Epsilon 2 as Second Allele 137
Hepatic Elastometry and Glissonian Line in the Assessment of Liver Fibrosis 137
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 135
Plasma PCSK9 levels and lipoprotein distribution are preserved in carriers of genetic HDL disorders 134
Psoriasis and Vitamin D: A Systematic Review and Meta-Analysis 134
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency. 132
Molecular and clinical characterization of a series of patients with childhood-onset lysosomal acid lipase deficiency. Retrospective investigations, follow-up and detection of two novel LIPA pathogenic variants 132
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 131
Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity 129
Troponin elevation does not always mean cardiac ischemia. 129
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. 128
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 128
Changes in the Expression of the Nuclear Matrix Intermediate Filament Complex Proteins are correlated with the Level of Differentiation in Human Prostate Cancer. 126
Molecular characterization of two patients with severe LCAT deficiency. 125
Appropriateness criteria for the management of lipid-lowering therapy with alirocumab in high cardiovascular risk patients. The opinion of a multidisciplinary group of Italian experts 123
First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias 122
Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia - Brief Report 122
Influence of beta(0)-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia : a study of patients with familial hypercholesterolemia from Sardinia. 119
Denaturing high-performance liquid chromatography (DHPLC) in the detection of mutations of ABCA1 gene in Familial HDL Deficiency. 118
A successful term pregnancy with severe hypertriglyceridaemia and acute pancreatitis. Clinical management and review of the literature 118
Effect of egg consumption on health outcomes: An updated umbrella review of systematic reviews and meta-analysis of observational and intervention studies 117
Online Questionnaire with Fibromyalgia Patients Shows Negative Correlations between Disease Severity and Adherence to Mediterranean Diet 115
Institution of an interdisciplinary IBD centre is associated with improved healthcare utilisation 115
Pharmacological treatment of a Sardinian patient affected by autosomal recessive hypercholesterolemia (ARH) 115
Long term follow-up of genetically confirmed patients with familial hypercholesterolemia treated with first and second-generation statins and then with PCSK9 monoclonal antibodies 115
The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families. 113
Among biomarkers of neutrophil activity, matrix metalloproteinases 8 independently predicts remission of metabolic syndrome 112
Beta-sitosterolaemia: a new nonsense mutation in the ABCG5 gene. 112
Nutraceutical pill containing berberine versus ezetimibe on plasma lipid pattern in hypercholesterolemic subjects and its additive effect in patients with familial hypercholesterolemia on stable cholesterol-lowering treatment. 112
Characterization of Three Kindred with Familial Combined Hypolipidemia Due to Loss of Function Mutations of ANGPTL3. 111
Author Correction: Cyclic fasting bolsters cholesterol biosynthesis inhibitors' anticancer activity 110
Clinical Expression of Familial Hypercholesterolemia in clusters of mutations of LDL-receptor gene causing receptor-defective or receptor-negative phenotype 109
The study of familial hypercholesterolemia in Italy: A narrative review 109
Effects of a mediterranean diet, dairy, and meat products on different phenotypes of dyslipidemia: A preliminary retrospective analysis 109
Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study 107
LIPA gene mutations affect the composition of lipoproteins: Enrichment in ACAT-derived cholesteryl esters 107
Evaluation of the efficacy of plant sterols supplement sterolip® ESI in patients with type IIA hypercholesterolemia in relation to Genetic variants modulating intestinal absorption of cholesterol 107
Characteristics, Physiopathology and Management of Dyslipidemias in Pregnancy: A Narrative Review 106
Le ipercolesterolemie familiari: forme dominanti e recessive (FH, FDB, FH3, FH4, ARH, beta-sitosterolemia, Deficit di 7alpha-idrossilasi). 106
Kidney disease and all-cause mortality in patients with COVID-19 hospitalized in Genoa, Northern Italy 105
Beta-thalassemia is a modifying factor of the clinical expression of familial hypercholesterolemia. 104
The impact of overweight on lipid phenotype in different forms of dyslipidemia: a retrospective cohort study 103
Evaluation of RNA messangers involved in lipid trafficking of human intestinal cells by RT-PCR with competimer technology and microchip electrophoresis. 103
The Real-Life Use of a Protein-Sparing Modified Fast Diet by Nasogastric Tube (ProMoFasT) in Adults with Obesity: An Open-Label Randomized Controlled Trial 102
Totale 14.814
Categoria #
all - tutte 63.283
article - articoli 61.885
book - libri 522
conference - conferenze 137
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 739
Totale 126.566


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.289 39 109 100 131 47 100 87 294 77 96 73 136
2022/20231.229 120 80 15 110 176 226 53 87 181 51 114 16
2023/2024981 37 89 22 103 107 187 60 65 35 57 86 133
2024/20252.885 110 186 125 223 293 280 250 466 134 136 300 382
2025/20266.458 637 234 517 673 744 439 861 308 487 671 422 465
2026/2027612 612 0 0 0 0 0 0 0 0 0 0 0
Totale 19.029